SCHEMBL9870560

SCHEMBL9870560

COc1c(C)nc(C(C)C)c(C(=O)O)c1-c1ccc(F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 14/20 0.50
DHODH Q02127 1/20 0.42
FABP3 P05413 1/20 0.41
FABP4 P15090 1/20 0.41
FABP5 Q01469 1/20 0.41
DPP4 P27487 1/20 0.41
DPP8 Q6V1X1 1/20 0.41
DPP9 Q86TI2 1/20 0.41
SLC10A2 Q12908 1/20 0.38
NPC1 O15118 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
ESR1 P03372 1/20 0.38
HMGCR P04035 1/20 0.38
CHRM1 P11229 1/20 0.38
TBXA2R P21731 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27293870 0.85 GCGR (0.49) GCGRFABP3FABP4FABP5DPP4
SCHEMBL8949663 0.84 GCGR (0.61) GCGRDHODHFABP3FABP4FABP5
SCHEMBL9870499 0.83 GCGR (0.47) GCGRFABP3FABP4FABP5DPP4
SCHEMBL2651071 0.82 GCGR (0.56) GCGRFABP3FABP4FABP5DPP4
SCHEMBL9872802 0.80 GCGR (0.45) GCGRFABP3FABP4FABP5DPP4
SCHEMBL9870958 0.80 GCGR (0.72) GCGRDHODHFABP3FABP4FABP5
SCHEMBL9873412 0.79 GCGR (0.52) GCGRFABP3FABP4FABP5DPP4
SCHEMBL5098308 0.79 GCGR (0.50) GCGRFABP3FABP4FABP5DPP4
SCHEMBL30858950 0.78 IKBKB (0.34) DHODHFABP3FABP4FABP5NPC1
SCHEMBL8879687 0.76 FABP3 (0.50) GCGRDHODHFABP3FABP4FABP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4997837-A Enzyme inhibitors WARNER-LAMBERT COMPANY (US) 1991-03-05 US disclosed
US-4906624-A 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis WARNER-LAMBERT COMPANY (US) 1990-03-06 US disclosed
EP-0306929-A2 6-[[(Substituted)pyridin-3-YL]alkyl]-and alkenyl]-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis WARNER-LAMBERT COMPANY (US) 1989-03-15 EP disclosed